BRKR vs TXG
Bruker Corporation - Common Stock · 10x Genomics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | BRKR | TXG |
|---|---|---|
| Price | $57.93 | $58.15 |
| Market Cap | $8.82B | $7.43B |
| P/E | — | — |
| P/B | 3.57 | 9.12 |
| P/S | 2.57 | 11.55 |
| ROE | -0.3% | -5.3% |
| Net Margin | -0.3% | -6.8% |
| Gross Margin | 45.9% | 69.1% |
| Revenue Growth | 2.1% | 5.2% |
| Dividend Yield | 0.35% | — |
| EPS | -$0.06 | -$0.34 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.